DoW Lung Cancer Translational Research Award
Defense Health Agency Contracting Activity - DHACA · Opportunity HT942526LCRPTRA
Deadline
September 2, 2026
38 days left
Award range
— – —
Total program funding
$9.1M
≈ 6 awards expected
PostedMay 5, 2026
Who can apply
- Unrestricted
About this opportunity
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II, Fast-Track Programs (SBIR/STTR): A Pilot Emphasis on Scientific Instrumentation. | U.S. National Science Foundation | July 27, 2026 1d left | — | |
| Integrated Data Systems & Services | U.S. National Science Foundation | July 28, 2026 2d left | $30M | |
| DoW Kidney Cancer, Concept Award | Defense Health Agency Contracting Activity - DHACA | July 28, 2026 2d left | — | Nonprofits Individuals |
| Disability and Rehabilitation Research Projects (DRRP) Program: Model Systems Knowledge Translation Center | Administration for Community Living | July 29, 2026 3d left | $850k | Nonprofits |